🇦🇺 Yartemlea in Australia

Yartemlea (NARSOPLIMAB) regulatory status in Australia.

Marketing authorisations

TGA

  • Status: likely_approved

TGA

  • Status: likely_approved

Yartemlea in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Australia

Frequently asked questions

Is Yartemlea approved in Australia?

Yes. TGA has authorised it; TGA has authorised it.

Who is the marketing authorisation holder for Yartemlea in Australia?

Omeros Corp is the originator. The local marketing authorisation holder may differ — check the official source linked above.